Covered recipient · General Payments record
ANDREW W ROGERS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2023–2024
$368.91
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $258.26 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $170.96 | 12 |
| Neurocrine BioSciences, Inc. | $30.02 | 2 |
| Lundbeck LLC | $24.45 | 1 |
| ITI, Inc. | $16.72 | 1 |
| Alkermes, Inc. | $16.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.74 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105867 | CMS |
| ABBVIE INC. | $5.62 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105869 | CMS |
| ABBVIE INC. | $23.60 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105871 | CMS |
| ABBVIE INC. | $23.60 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105873 | CMS |
| ABBVIE INC. | $6.96 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105875 | CMS |
| ABBVIE INC. | $23.89 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105877 | CMS |
| ABBVIE INC. | $21.62 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105879 | CMS |
| ABBVIE INC. | $10.80 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105881 | CMS |
| ABBVIE INC. | $5.16 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105883 | CMS |
| ABBVIE INC. | $6.45 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105885 | CMS |
| ABBVIE INC. | $17.60 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105887 | CMS |
| ABBVIE INC. | $1.92 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108105889 | CMS |
| Alkermes, Inc. | $16.11 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120583309 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.72 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143591699 | CMS |
| Lundbeck LLC | $24.45 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146083155 | CMS |
| Neurocrine Biosciences, Inc. | $14.49 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151005943 | CMS |
| Neurocrine Biosciences, Inc. | $15.53 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151001770 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.